Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup study

Tamaki Tanaka, Kazuhiro Takehara, Tomoka Usami, Masako Ishikawa, Eiji Kondo, Masahiro Kagabu, Kei Hirabayashi, Noriomi Matsumura, Shinya Sato, Masato Nishimura, Atsushi Arakawa, Keiichiro Nakamura, Yosuke Konno, Satoe Fujiwara, Kotaro Sueoka, Hiroko Nakamura, Iemasa Koh, Kimihiko Ito, Atsushi Hongo

Open source

DOI: 10.1016/j.gore.2025.101740
Published: 06
Container: Gynecologic Oncology Reports
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.gore.2025.101740,
  title = {Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup study},
  author = {Tamaki Tanaka and Kazuhiro Takehara and Tomoka Usami and Masako Ishikawa and Eiji Kondo and Masahiro Kagabu and Kei Hirabayashi and Noriomi Matsumura and Shinya Sato and Masato Nishimura and Atsushi Arakawa and Keiichiro Nakamura and Yosuke Konno and Satoe Fujiwara and Kotaro Sueoka and Hiroko Nakamura and Iemasa Koh and Kimihiko Ito and Atsushi Hongo},
  year = {2025},
  journal = {Gynecologic Oncology Reports},
  doi = {10.1016/j.gore.2025.101740},
  url = {https://doi.org/10.1016/j.gore.2025.101740}
}

RIS

TY  - JOUR
TI  - Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup study
AU  - Tamaki Tanaka
AU  - Kazuhiro Takehara
AU  - Tomoka Usami
AU  - Masako Ishikawa
AU  - Eiji Kondo
AU  - Masahiro Kagabu
AU  - Kei Hirabayashi
AU  - Noriomi Matsumura
AU  - Shinya Sato
AU  - Masato Nishimura
AU  - Atsushi Arakawa
AU  - Keiichiro Nakamura
AU  - Yosuke Konno
AU  - Satoe Fujiwara
AU  - Kotaro Sueoka
AU  - Hiroko Nakamura
AU  - Iemasa Koh
AU  - Kimihiko Ito
AU  - Atsushi Hongo
PY  - 2025
JO  - Gynecologic Oncology Reports
DO  - 10.1016/j.gore.2025.101740
UR  - https://doi.org/10.1016/j.gore.2025.101740
ER  -

APA

Tanaka, T., Takehara, K., Usami, T., Ishikawa, M., Kondo, E., Kagabu, M., Hirabayashi, K., Matsumura, N., Sato, S., Nishimura, M., Arakawa, A., Nakamura, K., Konno, Y., Fujiwara, S., Sueoka, K., Nakamura, H., Koh, I., Ito, K., & Hongo, A. (2025). Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup study. Gynecologic Oncology Reports. https://doi.org/10.1016/j.gore.2025.101740

Source records

doaj · retrieved 2026-09-26T07:55:43.526Z